The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement
Abstract
Pharmaceutical cocrystals are crystalline molecular complexes containing therapeutic molecules. They represent an emerging class of pharmaceutical materials offering the prospect of optimized physical properties. This article highlights important opportunities and challenges associated with the design and synthesis of pharmaceutical cocrystals. Cocrystallization is first placed into context with the more established approaches to physical property optimization of polymorph, hydrate, and salt selection. A directed, intermolecular-interaction-based approach to cocrystal design is described. The enhancement of specific physical properties, such as dissolution rate and physical stability, is illustrated by summarizing several recent reports. Synthetic approaches to cocrystallization are considered; in particular, the selectivity and screening-related opportunities afforded by solid-state grinding and solvent-drop grinding methods are discussed. Finally, an outlook on future developments summarizes the growth potential in this field, especially with regard to targeted, informatics-driven cocrystal screening approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cambridge Structural Database: a quarter of a million crystal structures and rising
Allen, F. H. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003890 · Cited by 9,898
Encoding and decoding hydrogen-bond patterns of organic compounds
Etter, M. C. (1990) · Accounts of Chemical Research · doi:10.1021/ar00172a005 · Cited by 4,591
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Polymorphism in Molecular Crystals
Bernstein, J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199236565.001.0001 · Cited by 1,346
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Topics in Current Chemistry: Inorganic Biochemistry
(1976) · Topics in Current Chemistry · doi:10.1007/bfb0045697 · Cited by 1,044
Physics and Chemistry of the Organic Solid State.
Dutton, D. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a056 · Cited by 993
Physics and Chemistry of the Organic Solid State
Fox, D. (1963) · Andalas University Repository (Andalas University) · Cited by 959
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Chemburkar, S. R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., et al. (2000) · Organic Process Research & Development · doi:10.1021/op000023y · Cited by 687
Vippagunta, S. R., Brittain, H. G., & Grant, D. J. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00097-7 · Cited by 670
Crystal structures of drugs: advances in determination, prediction and engineering
Datta, S., & Grant, D. J. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1280 · Cited by 583
Handbook of Pharmaceutical Salts: Properties, Selection, and Use
(2002) · Chemistry International -- Newsmagazine for IUPAC · doi:10.1515/ci.2002.24.3.20a · Cited by 532
Khankari, R. K., & Grant, D. J. W. (1995) · Thermochimica Acta · doi:10.1016/0040-6031(94)01952-d · Cited by 485
Salt selection for basic drugs
Gould, P. L. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90055-4 · Cited by 314
Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities
Bastin, R. J., Bowker, M. J., & Slater, B. J. (2000) · Organic Process Research & Development · doi:10.1021/op000018u · Cited by 245
Cited by
Mechanochemistry: opportunities for new and cleaner synthesis
James, S. L., Adams, C. J., Bolm, C., Braga, D., Collier, P., Friščić, T., Grepioni, F., Harris, K. D. M., Hyett, G., Jones, W., et al. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15171a · Cited by 3,056
Self-citationPharmaceutical cocrystals: along the path to improved medicines
Duggirala, N. K., Perry, M. L., Almarsson, Ö., & Zaworotko, M. J. (2016) · Chemical Communications · doi:10.1039/c5cc08216a · Cited by 928
Friščić, T., Childs, S. L., Rizvi, S. A. A., & Jones, W. (2009) · CrystEngComm · doi:10.1039/b815174a · Cited by 649
Self-citationPharmaceutical cocrystals and poorly soluble drugs
Thakuria, R., Delori, A., Jones, W., Lipert, M. P., Roy, L., & Rodríguez-Hornedo, N. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.043 · Cited by 614
Self-citationCrystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs
Bolla, G., Sarma, B., & Nangia, A. K. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00987 · Cited by 597
Metadata
- Authors
- Jones, W., Motherwell, W. D. S., & Trask, A. V.
- Venue
- MRS Bulletin
- Published
- 2006-11
- Volume
- 31
- Issue
- 11
- Pages
- 875-879
- ISSN
- 0883-7694 (ISSN-L)
- 1938-1425
- OpenAlex
- W2018538448
- Cited by
- 393
- References
- 15
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.